Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-03 Piacquad David SVP, Business Development Shares withheld for taxes −220 $239.64 $53K 44,787
2021-05-01 Piacquad David SVP, Business Development Shares withheld for taxes −139 $239.64 $33K 45,007
2021-04-30 Piacquad David SVP, Business Development Grant or award +709 45,146
2021-04-30 Piacquad David SVP, Business Development Grant or award · Nqso (Right to Buy) +6,159 6,159
2021-04-27 Piacquad David SVP, Business Development Shares withheld for taxes −128 $255.52 $33K 44,437
2021-03-19 Piacquad David SVP, Business Development Shares withheld for taxes −991 $244.42 $242K 44,565
2021-03-02 Piacquad David SVP, Business Development Grant or award +2,648 45,504

Page 1 of 1 · 7 trades